2:18AM 3SBIO misses by $0.03; beats on revs; reaffirms FY rev guidance, in-line with consensus (SSRX) 18.15 : Reports Q1 (Mar) EPS per ADS of $0.15 vs $0.18 consensus; revs increased 22.7% YoY to $18.1 mln vs $17.6 mln consensus. Co reaffirms guidance for FY11 (Dec), sees FY11 (Dec) revs of $76-82 mln vs. $79.87 mln Thomson Reuters consensus.